•
Mar 31, 2018

ResMed Q3 2018 Earnings Report

Total Revenue
$592M
Previous year: $514M
+15.1%
EPS
$0.92
Previous year: $0.71
+29.6%
Gross Profit
$344M
Previous year: $300M
+14.9%
Cash and Equivalents
$704M
Previous year: $827M
-14.9%
Free Cash Flow
$136M
Previous year: $53M
+156.9%
Total Assets
$3.53B
Previous year: $3.42B
+3.3%

ResMed

ResMed